semaglutide weight loss cotswold-southpark Compound South Park Tackles Ozempic Craze

Semaglutide, approved for type 2 diabetes in 2017 and for obesity in 2021, is a fully human GLP-1 receptor agonist

You can also schedule an appointment online

Chronic hyperglycemia is responsible for many complications, including cardiovascular disease, nerve damage (neuropathy), kidney damage (nephropathy), eye disease, unintentional weight loss (due to metabolism of fat and muscle, as cells do not have access to glucose to metabolize), and diabetic ketoacidosis

[PMID: 7897585] PubMed record related to this compound for laboratory literature review

Patients must demonstrate recent prescription history and supply records from authorized healthcare providers to ensure treatment continuity

Improved insulin resistance and lipid metabolism by cinnamon extract through activation of peroxisome proliferator-activated receptors